A Phase Ib study of CD40 agonistic monoclonal antibody APX005M together with gemcitabine (Gem) and nab-paclitaxel (NP) with or without nivolumab (Nivo) in untreated metastatic ductal pancreatic adenocarcinoma (PDAC) patients Meeting Abstract

  

Authors:	O'Hara, M. H.; O'Reilly, E. M.; Rosemarie, M.; Varadhachary, G.; Wainberg, Z. A.; Ko, A.; Fisher, G. A.; Rahma, O.; Lyman, J. P.; Cabanski, C. R.; Carpenter, E. L.; Hollmann, T.; Gherardini, P. F.; Kitch, L.; Selinsky, C.; LaVallee, T.; Trifan, O. C.; Dugan, U.; Hubbard-Lucey, V. M.; Vonderheide, R. H.
Abstract Title:	A Phase Ib study of CD40 agonistic monoclonal antibody APX005M together with gemcitabine (Gem) and nab-paclitaxel (NP) with or without nivolumab (Nivo) in untreated metastatic ductal pancreatic adenocarcinoma (PDAC) patients
Meeting Title:	110th Annual Meeting of the American Association for Cancer Research (AACR)
Journal Title:	Cancer Research
Volume:	79
Issue:	13 Suppl.
Meeting Dates:	2019 Mar 29-Apr 3
Meeting Location:	Atlanta, GA
ISSN:	0008-5472
Publisher:	American Association for Cancer Research
Date Published:	2019-07-01
Language:	English
ACCESSION:	WOS:000488129900004
DOI:	10.1158/1538-7445.Am2019-ct004
PROVIDER:	wos
Notes:	Meeting Abstract: CT004 -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/156076